Company Theseus Pharmaceuticals, Inc.
Equities
THRX
US88369M1018
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
- | - | ||
59 | - | ||
66 | - | ||
Bradford Dahms
PSD | President | 36 | 21-04-30 |
Leonard Rozamus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Katie Dahlstrom
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Benjamin Enerson
LAW | General Counsel | - | - |
Comptroller/Controller/Auditor | - | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradford Dahms
PSD | President | 36 | 21-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,649,172 | 44,649,172 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |